A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma

NCT03136653 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma in Relapse

Interventions

BIOLOGICAL: MP0250 plus BOR+DEX

Sponsor

Molecular Partners AG